A carregar...
Randomised Clinical Trial: Pregabalin Versus Placebo for Irritable Bowel Syndrome
BACKGROUND: Pregabalin is a calcium channel α2δ ligand that modifies visceral hypersensitivity in IBS patients. Clinical data for pregabalin in IBS are lacking. AIM: To test the efficacy of pregabalin on gastrointestinal symptoms in IBS patients METHODS: A double-blind, placebo-controlled trial was...
Na minha lista:
| Publicado no: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6349499/ https://ncbi.nlm.nih.gov/pubmed/30663077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15077 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|